On Invalid Date, Arca Biopharma (NASDAQ: ABIO) reported Q1 2023 earnings per share (EPS) of -$0.09, up 60.87% year over year. Total Arca Biopharma earnings for the quarter were -$1.35 million. In the same quarter last year, Arca Biopharma's earnings per share (EPS) was -$0.23.
As of Q2 2023, Arca Biopharma's earnings has grown year over year. Arca Biopharma's earnings in the past year totalled -$8.00 million.
What is ABIO's earnings date?
Arca Biopharma's earnings date is Invalid Date. Add ABIO to your watchlist to be reminded of ABIO's next earnings announcement.
What was ABIO's revenue last quarter?
On Invalid Date, Arca Biopharma (NASDAQ: ABIO) reported Q1 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Arca Biopharma's revenue was $0.00.
What was ABIO's revenue growth in the past year?
As of Q2 2023, Arca Biopharma's revenue has grown null year over year. Arca Biopharma's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.